Login / Signup

Transplant of organs from donors with positive SARS-CoV-2 nucleic acid testing: A report from the organ procurement and transplantation network ad hoc disease transmission advisory committee.

Jason D GoldmanStephanie Marie PouchAnn E WoolleySarah E BookerCourtney T JettCole FoxGerald J BerryKelly E DunnChak-Sum HoMichelle KittlesonDong Heun LeeDeborah J LevineCharles C MarboeGary F MarklinRaymund R RazonableSarah TaimurHelen S TeJudith A AnesiCynthia E FisherMarty T SellersAnil J TrindadeR Patrick WoodLorenzo ZaffiriMarilyn E LeviDavid KlassenMarian G MichaelsRicardo M La HozLara A Danziger-Isakov
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2023)
Transplantation of SARS-CoV-2 NAT+ donor organs appears safe for short-term outcomes of death and graft loss and ameliorates the organ shortage. Further study is required to assure comparable longer term outcomes.
Keyphrases
  • sars cov
  • nucleic acid
  • respiratory syndrome coronavirus
  • cell therapy
  • preterm infants
  • adipose tissue
  • gestational age
  • metabolic syndrome
  • insulin resistance
  • coronavirus disease
  • weight loss